Pharma
Nearly 70 million Indians live with some form of rare genetic disease. But for global drug makers, the country isn’t a priority. Unless local firms step up their R&D efforts, the government remedies its lack of policy preparedness, and obscene drug prices are tamed, this population will oscillate between helplessness and despair.
Anushka Panda, an all-India CBSE topper last year, suffers from a dangerous rare disease that has no medication available in India.
View Comments
Published by
Staff
5 years ago